ASENSUS SURGICAL INC (ASXC)
US04367G1031 - Common Stock
Small Packages, Big Gains: 3 Penny Stocks to Buy as Q2 Kicks Off
These three penny stocks certainly look well-positioned to ride the next wave of growth higher in their diverse market niches.
Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG
KARL STORZ to provide up to $20 million in bridge financing...
ASXC Stock Earnings: Asensus Surgical Beats EPS, Beats Revenue for Q4 2023
ASXC stock results show that Asensus Surgical beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023
RESEARCH TRIANGLE PARK, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is...
Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024
RESEARCH TRIANGLE PARK, N.C., March 15, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, announced today that it plans to release fourth quarter and full year 2023 financial and operating results after the market closes on Thursday, March 21, 2024. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will be concurrently webcast.
Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
RESEARCH TRIANGLE PARK, N.C., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference. The Company’s virtual presentation will take place on Tuesday, March 12, 2024 at 4:40 pm Eastern Time.
Asensus Surgical Celebrates 1,000 Senhance Cases Completed at Three Global Hospitals
RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing...
7 Mighty Healthcare Stocks Changing the Game of Medicine
Thanks to the permanent relevance of medical innovations, investors ought to consider looking at these healthcare stocks.
Asensus Surgical Announces Nagoya University Hospital in Japan to Initiate Senhance Surgery Program
The Fourth Hospital to Initiate a Senhance® Surgical System Dedicated to Pediatric Procedures...
Asensus Surgical Provides Preliminary 2023 Year-End Corporate Update
RESEARCH TRIANGLE PARK, N.C., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing...
The 7 Hottest Tech Stocks to Watch in 2024
With the innovation machinery running at full speed, investors may want to target these ideas for hottest tech stocks of 2024.
Asensus Surgical Completes In Vivo Surgeon Lab for LUNA Surgical Robotic System
Surgeons Applaud LUNA's Innovative Capabilities...
Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
RESEARCH TRIANGLE PARK, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing...
Asensus Announces Sale of Senhance Robotic System in Romania
Senhance® System to be placed at a pediatric hospital in Timisoara, Romania...
3 Stocks at the Forefront of Medical Robotics
Although the concept of medical robotics stocks is incredibly risky, the sector also offers tremendous upside for the intrepid.
Senhance Robotic System Sold by Asensus Surgical
Senhance® System to be placed at a hospital in the Commonwealth of Independent States...
Cantor downgrades Asensus to neutral, cites capital needs (NYSE:ASXC)
Cantor Fitzgerald downgraded Asensus Surgical (ASXC) to neutral due to the company’s capital needs, which estimates to be around $60M next year. Read more here.
Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2023
RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the third quarter 2023.
Asensus Surgical sees gains following equipment sale (NYSE:ASXC)
Asensus Surgical (NYSE:ASXC) announced on Tuesday sale of a Senhance Surgical System to its distribution partner.The equipment will be deployed in a...
Asensus Surgical Announces Sale of Senhance Robotic System
Senhance® System to be placed at a pediatric hospital in the Commonwealth of Independent States...
Asensus Surgical, Inc. Announces Agreement with Flex for Design and Advanced Manufacturing Services for the LUNA™ Surgical System
RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing...
Why Did AMC Stock Just Hit a Record Low?
AMC Entertainment (AMC) stock just hit a new low on Thursday as the movie theater company continues to step on investors' toes.
Why Is Asensus Surgical (ASXC) Stock Up 18% Today?
Asensus Surgical (ASXC) stock is rising higher on Thursday as investors react to news of a collaboration with Nvidia NVDA).
Asensus Surgical stock jumps on deal with NVIDIA (NYSE:ASXC)
Asensus Surgical (ASEN) added ~28% pre-market Thursday after announcing a tech collaboration with NVIDIA (NVDA) to improve its Intelligent Surgical Unit. Read more here.